» Articles » PMID: 23503614

Natural History of a Medulloblastoma: 30 months of Wait and See in a Child with a Cerebellar Incidentaloma

Overview
Specialty Pediatrics
Date 2013 Mar 19
PMID 23503614
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: With the increasing use of neuroimaging studies, the discovery of incidental neoplastic lesions is becoming more frequent. However, standard procedures are lacking, and little is known about their optimal management.

Case Report: We here present the case of a boy with a cerebellar mass incidentally discovered on a CT scan performed after head trauma. In another scan performed after another incident of head trauma 14 months earlier, the lesion could be seen after retrospective examination. In view of the asymptomatic clinical and stable radiological status and the presumed diagnosis of a low-grade glioma, a watch-and-wait strategy was elected. After clinical and radiological progression was observed, the tumour was resected, 2½ years after the initial imaging study. Histological evaluation revealed a WNT pathway-activated classical medulloblastoma.

Discussion: To our knowledge, this is the first description of such a long natural history and pre-symptomatic period of a medulloblastoma. The long period of stability followed by a period of accelerated tumour growth is compatible with increasing biological aggressiveness, possibly related to the stepwise accumulation of genetic changes.

Citing Articles

Slow-growing WNT medulloblastoma with atypical magnetic resonance imaging findings: illustrative case.

Mizushima M, Okamoto M, Yamaguchi S, Oki S, Motegi H, Sugiyama M J Neurosurg Case Lessons. 2023; 6(7).

PMID: 37728284 PMC: 10555650. DOI: 10.3171/CASE23277.


Natural History of Medulloblastoma in a Child with Neurofibromatosis Type I.

Golpayegani M, Salari F, Habibi Z, Anbarlouei M, Mahdavi A, Nejat F Asian J Neurosurg. 2018; 13(3):918-920.

PMID: 30283582 PMC: 6159073. DOI: 10.4103/ajns.AJNS_35_18.

References
1.
Brasme J, Chalumeau M, Doz F, Lacour B, Valteau-Couanet D, Gaillard S . Interval between onset of symptoms and diagnosis of medulloblastoma in children: distribution and determinants in a population-based study. Eur J Pediatr. 2011; 171(1):25-32. DOI: 10.1007/s00431-011-1480-z. View

2.
Korshunov A, Benner A, Remke M, Lichter P, von Deimling A, Pfister S . Accumulation of genomic aberrations during clinical progression of medulloblastoma. Acta Neuropathol. 2008; 116(4):383-90. DOI: 10.1007/s00401-008-0422-y. View

3.
Nelson M, Diebler C, Forbes W . Paediatric medulloblastoma: atypical CT features at presentation in the SIOP II trial. Neuroradiology. 1991; 33(2):140-2. DOI: 10.1007/BF00588252. View

4.
Northcott P, Korshunov A, Witt H, Hielscher T, Eberhart C, Mack S . Medulloblastoma comprises four distinct molecular variants. J Clin Oncol. 2010; 29(11):1408-14. PMC: 4874239. DOI: 10.1200/JCO.2009.27.4324. View

5.
Ellison D, Kocak M, Dalton J, Megahed H, Lusher M, Ryan S . Definition of disease-risk stratification groups in childhood medulloblastoma using combined clinical, pathologic, and molecular variables. J Clin Oncol. 2010; 29(11):1400-7. PMC: 3525837. DOI: 10.1200/JCO.2010.30.2810. View